Le Lézard
Classified in: Health
Subjects: NPT, PER

AACC Elects New Leaders to Serve in 2018


WASHINGTON, Oct. 13, 2017 /PRNewswire-USNewswire/ -- AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Carmen L. Wiley, PhD, DABCC, FACB, has been elected to serve on the AACC Board of Directors as president-elect starting in January 2018. Following this, she will serve successive terms as the association's president from January 2019-July 2020 and as past president from August 2020-July 2021. The AACC membership also elected two new directors to the association's Board who will take office at the beginning of 2018.

Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.

"I am deeply honored that AACC's membership has chosen me to serve the organization and profession in this capacity," said Dr. Wiley. "Laboratory medicine professionals play an essential role in high quality patient care by ensuring that the right tests are used to diagnose health issues and that the results are interpreted correctly. As president-elect, I look forward to working with AACC's members, leadership, and staff to increase collaboration between lab medicine professionals and the rest of the healthcare team so that clinicians and patients can reap the full benefits of our members' expertise."

Dr. Wiley is regional manager of Medical and Scientific Affairs, Cardiac at Roche Diagnostics in Spokane, Washington. An active member of AACC since 1999, she is currently a member of the association's Board of Directors as well as the Editorial Review Board for Lab Tests Online, AACC's online resource that helps patients to understand clinical laboratory tests. Previously, she served as scientific director of the reference laboratory PAML and as co-director of chemistry, immunology, and point-of-care at Providence Health and Services, Sacred Heart Hospital in Spokane, Washington.

AACC Board Members

Shannon Haymond, PhD, DABCC, and David B. Sacks, MB ChB, FRCPath, will serve 3-year terms as members of AACC's Board of Directors. William E. Winter, MD, DABCC, FACB, will also join the Board as a new member at the beginning of 2018, and will serve a 1-year term coinciding with his term as president of AACC Academy, the association's home for distinguished laboratory experts who shape science in the field.

Dr. Haymond is director of clinical chemistry and mass spectrometry at the Ann & Robert H. Lurie Children's Hospital of Chicago and serves as an associate professor of pathology at Northwestern University Feinberg School of Medicine. An AACC member since 1998, Dr. Haymond is chair of the association's Pediatric and Maternal-Fetal Medicine Division, a member of Lab Tests Online's Editorial Review Board, a member of the AACC Annual Meeting Strategic Advisory Group, and a course author for AACC Learning Lab, an adaptive online education resource for lab professionals. 

Dr. Sacks is chief of clinical chemistry and a senior investigator at the National Institutes of Health in Bethesda, Maryland. He has been a member of AACC since 1986, and his current involvement with the association includes serving as an associate editor of AACC's journal Clinical Chemistry and as chair of the organization's Clinical Societies Collaboration Committee. Outside of AACC, Dr. Sacks is also involved with numerous committees focused on improving testing for diabetes.

Dr. Winter is director of the University of Florida (UF) Health Pathology, Endocrine Autoantibody Laboratory in Gainesville and is a professor of pathology, immunology, and laboratory medicine; pediatrics; and molecular genetics and microbiology at UF. In addition, he is principal investigator for the National Institutes of Health (NIH)-funded Type 1 Diabetes TrialNet Islet Cell Autoantibody Core Laboratory and the NIH-funded Islet Autoantibody Standardization Program. He joined AACC in 1993, and was the 2016 recipient of the AACC Academy Professor Alvin Dubin Award for Outstanding Contributions to the Profession and the Academy.    

About AACC
Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.

Christine DeLong
AACC
Manager, Communications & PR
(p) 202.835.8722
[email protected]

Molly Polen
AACC
Senior Director, Communications & PR
(p) 202.420.7612
(c) 703.598.0472
[email protected]

SOURCE AACC


These press releases may also interest you

at 13:26
In a bid to foster excellence and innovation in the healthcare industry, the esteemed Dr. Vidal Sheen proudly announces the launch of The Dr. Vidal Sheen Grant for Healthcare Students. With a robust focus on academic prowess, compassionate care, and...

at 13:17
Rexall is proud to unveil its first Pharmacist Care Walk-In Clinic in Barrie, Ontario on Friday, April 19. Located at 353 Duckworth Street, the clinic will offer personalized care to the community while providing immediate pharmacist treatment for...

at 13:13
Caring for communities extends beyond life-changing work in operating rooms and physician offices. Hartford HealthCare leadership today highlighted its corporate responsibility to environmental, social and economic sustainability in announcing its...

at 13:04
Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch ? Sirolimus drug coated balloon (DCB), for the management of in-stent...

at 12:30
The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best...

at 12:10
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...



News published on and distributed by: